MIT and Microsoft Use AI to Design Nanoparticle Sensors That Detect Early-Stage Cancer in Urine
Summary
MIT and Microsoft researchers are using AI to design nanoparticle sensors that detect early-stage cancer through a simple urine test, with scientists now working to develop an at-home diagnostic kit capable of identifying up to 30 types of cancer.
Key Points
- MIT and Microsoft researchers use AI to design molecular sensors capable of detecting early signs of cancer through a simple urine test.
- Nanoparticles coated with AI-designed peptides circulate in the body and release detectable reporter molecules into urine when they encounter cancer-linked enzymes called proteases.
- Scientists are now collaborating with ARPA-H to develop an at-home diagnostic kit that could potentially detect up to 30 types of early-stage cancer, with the peptides also showing promise in cancer therapeutics.